000909507 001__ 909507
000909507 005__ 20230123110645.0
000909507 0247_ $$2doi$$a10.1093/neuonc/noac131
000909507 0247_ $$2ISSN$$a1522-8517
000909507 0247_ $$2ISSN$$a1523-5866
000909507 0247_ $$2Handle$$a2128/33045
000909507 0247_ $$2pmid$$a35674736
000909507 0247_ $$2WOS$$aWOS:000807656300001
000909507 037__ $$aFZJ-2022-03213
000909507 082__ $$a610
000909507 1001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b0$$eCorresponding author$$ufzj
000909507 245__ $$aInvestigational PET tracers in neuro-oncology—What’s on the horizon? A report of the PET/RANO group
000909507 260__ $$aOxford$$bOxford Univ. Press$$c2022
000909507 3367_ $$2DRIVER$$aarticle
000909507 3367_ $$2DataCite$$aOutput Types/Journal article
000909507 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670836381_17320
000909507 3367_ $$2BibTeX$$aARTICLE
000909507 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000909507 3367_ $$00$$2EndNote$$aJournal Article
000909507 520__ $$aMany studies in patients with brain tumors evaluating innovative PET tracers have been published in recent years, and the initial results are promising. Here, the Response Assessment in Neuro-Oncology (RANO) PET working group provides an overview of the literature on novel investigational PET tracers for brain tumor patients. Furthermore, newer indications of more established PET tracers for the evaluation of glucose metabolism, amino acid transport, hypoxia, cell proliferation, and others are also discussed. Based on the preliminary findings, these novel investigational PET tracers should be further evaluated considering their promising potential. In particular, novel PET probes for imaging of translocator protein and somatostatin receptor overexpression as well as for immune system reactions appear to be of additional clinical value for tumor delineation and therapy monitoring. Progress in developing these radiotracers may contribute to improving brain tumor diagnostics and advancing clinical translational research.
000909507 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000909507 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000909507 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b1$$ufzj
000909507 7001_ $$0P:(DE-HGF)0$$aAlbert, Nathalie L$$b2
000909507 7001_ $$0P:(DE-HGF)0$$aLaw, Ian$$b3
000909507 7001_ $$0P:(DE-HGF)0$$aKim, Michelle M$$b4
000909507 7001_ $$0P:(DE-HGF)0$$aVillanueva-Meyer, Javier E$$b5
000909507 7001_ $$00000-0002-9204-7038$$aSoffietti, Riccardo$$b6
000909507 7001_ $$0P:(DE-HGF)0$$aWen, Patrick Y$$b7
000909507 7001_ $$00000-0002-1748-174X$$aWeller, Michael$$b8
000909507 7001_ $$0P:(DE-HGF)0$$aTonn, Joerg C$$b9
000909507 773__ $$0PERI:(DE-600)2094060-9$$a10.1093/neuonc/noac131$$gp. noac131$$n11$$p1815–1826$$tNeuro-Oncology$$v24$$x1522-8517$$y2022
000909507 8564_ $$uhttps://juser.fz-juelich.de/record/909507/files/Invoice_E15324838.pdf
000909507 8564_ $$uhttps://juser.fz-juelich.de/record/909507/files/POSTPRINT.pdf$$yPublished on 2022-06-08. Available in OpenAccess from 2023-06-08.
000909507 8767_ $$8E15324838$$92022-06-17$$a1200184626$$d2022-09-27$$eColour charges$$jZahlung erfolgt
000909507 909CO $$ooai:juser.fz-juelich.de:909507$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000909507 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b0$$kFZJ
000909507 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b1$$kFZJ
000909507 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000909507 9141_ $$y2022
000909507 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000909507 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-03
000909507 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-03
000909507 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-08$$wger
000909507 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-08
000909507 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-08
000909507 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-08
000909507 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-08
000909507 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEURO-ONCOLOGY : 2021$$d2022-11-08
000909507 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-08
000909507 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bNEURO-ONCOLOGY : 2021$$d2022-11-08
000909507 920__ $$lyes
000909507 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000909507 980__ $$ajournal
000909507 980__ $$aVDB
000909507 980__ $$aUNRESTRICTED
000909507 980__ $$aI:(DE-Juel1)INM-3-20090406
000909507 980__ $$aAPC
000909507 9801_ $$aAPC
000909507 9801_ $$aFullTexts